After 15 years of successive randomized, controlled trials, indications for transcatheter aortic
valve replacement (TAVR) are rapidly expanding. In the coming years, this procedure could …

OBJECTIVES We sought to provide further evidence on the safety and efficacy of aortic
valve neocuspidization (AVNeo) using autologous pericardium in adult patients with aortic …

Background Transcatheter aortic valve replacement (TAVR)‐in‐TAVR is a possible
treatment for transcatheter heart valve (THV) degeneration. However, the displaced leaflets …

Transcatheter therapies for the treatment of structural heart diseases (SHD) have expanded
dramatically over the last years, thanks to the developments and improvements of devices …

Background Incidence of coronary access (CA) after transcatheter aortic valve replacement
(TAVR) at long‐term follow‐up remains unknown. CA and percutaneous coronary …

Background: Conduction disturbances after transcatheter aortic valve replacement (TAVR)
are often transient. Limited data exist on anatomic factors predisposing to pacemaker …

Bicuspid aortic valve (BAV) is a common congenital valvular malformation, which may lead
to early aortic valve disease and bicuspid-associated aortopathy. A novel BAV classification …

Background: Coronary artery disease and aortic stenosis often coexist. Transcatheter aortic
valve implantation (TAVI) has emerged as a valid therapeutic option for younger, lower-risk …

Transcatheter aortic valve replacement (TAVR) is a rapidly growing field enabling
replacement of diseased aortic valves without the need for open heart surgery. However …

Objective We sought to conduct a systematic review and meta-analysis of clinical adverse
events in patients undergoing transcatheter aortic valve replacement (TAVR) with bicuspid …